The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study

Pathogens and Disease
Jacob D PiersonLarry J Forney

Abstract

Menstrual toxic shock syndrome is associated with vaginal colonization by Staphylococcus aureus strains that encode toxic shock syndrome toxin 1 (tst+). Interestingly, a small proportion of women are colonized by S. aureus tst+ but do not have symptoms of toxic shock syndrome. Here we sought to determine if differences in the species composition of vaginal bacterial communities reflect a differential risk of colonization by S. aureus capable of producing toxic shock syndrome toxin 1 (TSST-1). The composition of vaginal communities of women that were or were not colonized with S. aureus tst+ were compared based on terminal restriction fragment length polymorphism (T-RFLP) profiles and sequences of cloned 16S rRNA genes. There were no detectable differences in community composition or species rank abundance between communities of women vaginally colonized with S. aureus tst+ as compared to those that were not. Phylogenetic analysis of cloned 16S rRNA gene sequences showed that the predominant members of communities of women colonized with S. aureus tst+ were indistinguishable from those of other healthy women. The data suggest that the numerically dominant members of vaginal communities do not preclude colonization and proliferat...Continue Reading

References

Jan 1, 1991·Annual Review of Immunology·A HermanA M Pullen
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J M MusserR K Selander
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Feb 1, 1983·The Journal of Infectious Diseases·P M Schlievert, D A Blomster
Apr 1, 1981·The Journal of Infectious Diseases·P M SchlievertR D Nishimura
Apr 1, 1982·The Journal of Infectious Diseases·M T OsterholmJ M Vergeront
Jul 1, 1995·Clinical Microbiology Reviews·M Kotb
Aug 1, 1996·International Journal of Food Microbiology·R C WhitingJ G Phillips
Dec 22, 1999·Emerging Infectious Diseases·R A HajjehB A Perkins
Jan 11, 2000·Clinical Microbiology Reviews·M M DingesP M Schlievert
Jan 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martin LlewelynDaniel M Altmann
May 20, 2008·Applied and Environmental Microbiology·Brian B OakleyDavid N Fredricks
Aug 20, 2008·Infection and Immunity·Kati SeidlBrigitte Berger-Bächi
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jacques RavelLarry J Forney
Jan 15, 2013·Applied and Environmental Microbiology·Roderick A MacPheeGregor Reid
May 4, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ian KimberMalak Kotb
Aug 26, 2014·PloS One·Janneke H H M van de WijgertVicky Jespers

❮ Previous
Next ❯

Citations

May 29, 2020·Clinical Microbiology Reviews·Patrick M Schlievert, Catherine C Davis
Nov 9, 2020·Microbial Cell Factories·Wallace Jeng Yang CheeLeslie Thian Lung Than
May 4, 2020·Current Opinion in Microbiology·Chunyi Zhou, Paul D Fey

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.